Compare Mutual Funds
Pros | Beats FD returns for both 3Y & 5Y duration. | |||
Cons | 3Y returns in the bottom 25% of the category. |
INDMoney rank | 8/9 | |||
Category | Equity, Sector - Healthcare | |||
Fund Age | 10 Years 10 Months | |||
Fund AUM | ₹1565 Cr | |||
Min Investment |
| |||
Expense Ratio | 0.97% | |||
Exit Load | 0.25% | |||
Benchmark Index | Nifty Pharma TR INR |
No of Holdings | 39 | |||
Top 5 Holdings |
| |||
No of Sectors | 3 | |||
Top 3 Sectors |
| |||
Equity % | 99.14% | |||
Debt % | - | |||
P/E | 40.58 | |||
P/B | 6.28 | |||
Credit Quality | - | |||
Modified Duration | - | |||
YTM | - |
1-Month Return | -2.09% | |||
3-Month Return | 5.05% | |||
6-Month Return | 13.94% | |||
1-Year Return | 7.98% | |||
3-Year Return | 18.9% | |||
5-Year Return | 14.06% |
Sharpe | 0.89 | |||
Alpha | -0.74 | |||
Beta | 0.99 | |||
Standard Deviation | 16.38 | |||
Information Ratio | -0.28 |
Description | Tata India Pharma & Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | |||
Managers | Rajat Srivastava |
Most Popular Comparisons
